These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 294133)

  • 21. [The long term treatment of rheumatoid arthritis with D-penicillamine].
    Krüger HH
    Verh Dtsch Ges Rheumatol; 1969; 1():387-94. PubMed ID: 4997350
    [No Abstract]   [Full Text] [Related]  

  • 22. [Penicillamine-induced pemphigus].
    Kind P; Goerz G; Gleichmann E; Plewig G
    Hautarzt; 1987 Sep; 38(9):548-52. PubMed ID: 3319968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    J Rheumatol Suppl; 1981; 7():103-6. PubMed ID: 6939871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of rheumatoid arthritis using D-penicillamine].
    Ott VR; Schmidt KL
    Internist (Berl); 1974 Jun; 15(6):328-35. PubMed ID: 4211090
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased binding of D-penicillamine to monocytes in rheumatoid arthritis.
    Watanabe H; Grimsley G; Major GA; Dawkins RL
    Clin Immunol Immunopathol; 1986 Apr; 39(1):173-8. PubMed ID: 3948434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for assaying D-penicillamine in a clinical setting.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):31-4. PubMed ID: 6723121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
    Trnavský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
    [No Abstract]   [Full Text] [Related]  

  • 30. [D-penicillamine in rheumatoid arthritis].
    Har-Zahav Y; Pras M; Biran D; Kaplinsky N
    Harefuah; 1979 Jan; 96(2):99-101. PubMed ID: 478384
    [No Abstract]   [Full Text] [Related]  

  • 31. An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy.
    Webley M; Coomes EN
    J Rheumatol; 1979; 6(1):20-4. PubMed ID: 439106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [D-penicillamine in rheumatoid arthritis (author's transl)].
    Feldges DH; Müller W
    Schweiz Rundsch Med Prax; 1975 Dec; 64(52):1665-9. PubMed ID: 1219714
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of common rheumatoid polyarthritis with D-penicillamine. Study of a series of 22 cases].
    Lièvre JA; Camus JP; Bénichou C; Guillien P; Crouzet J
    Ann Med Interne (Paris); 1971 May; 122(5):655-62. PubMed ID: 5563719
    [No Abstract]   [Full Text] [Related]  

  • 34. [Laboratory findings in patients with rheumatoid arthritis during D-penicillamine- and goldtherapy (author's transl)].
    Stojan B; Hasler F
    Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1435-6. PubMed ID: 928308
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our experience in the treatment of rheumatoid arthritis with D-penicillamine].
    Wysocka K; Kiczak J; Hawrylak E
    Wiad Lek; 1980 Apr; 33(8):607-10. PubMed ID: 7405223
    [No Abstract]   [Full Text] [Related]  

  • 36. [Iatrogenic pulmonary pathology in patients with rheumatoid arthritis treated with D-penicillamine].
    Isanova TS; Krel' AA
    Sov Med; 1979 Oct; (10):9-11. PubMed ID: 524179
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis].
    Brenner S; Caspi D; Tchetchik R; Krakowski A; Yaron M
    Harefuah; 1983 Feb; 104(3):94-6. PubMed ID: 6618302
    [No Abstract]   [Full Text] [Related]  

  • 38. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].
    Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI
    Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994
    [No Abstract]   [Full Text] [Related]  

  • 39. D-penicillamine-induced myasthenia gravis in rheumatoid arthritis.
    Froelich CJ; Hashimoto F; Searles RP; Bankhurst AD
    J Rheumatol; 1979; 6(2):237-9. PubMed ID: 458795
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis].
    Ongerboer de Visser BW; van Soesbergen RM
    Ned Tijdschr Geneeskd; 1978 Dec; 122(52):2055-8. PubMed ID: 732905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.